Ascend Wellness Holdings (AAWH) Cash & Equivalents (2020 - 2026)

Ascend Wellness Holdings' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $60.9 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 39.1% year-over-year to $60.9 million in Q1 2026; TTM through Mar 2026 was $60.9 million, a 39.1% decrease from a year earlier, with the FY2025 full-year figure at $85.7 million, down 2.92% from the prior year.
• Cash & Equivalents retreated to $60.9 million in Q1 2026 per AAWH's latest filing, from $85.7 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $143.8 million in Q1 2022 and bottomed at $60.9 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $83.7 million (2024), against an average of $86.3 million.
• Biggest YoY gain for Cash & Equivalents was 129.59% in 2022; the steepest drop was 52.31% in 2022.
• Year by year, Cash & Equivalents stood at $74.1 million in 2022, then slipped by 2.21% to $72.5 million in 2023, then advanced by 21.72% to $88.3 million in 2024, then retreated by 2.92% to $85.7 million in 2025, then slipped by 28.89% to $60.9 million in 2026.
• Per Business Quant, the three latest AAWH Cash & Equivalents figures stand at $60.9 million (Q1 2026), $85.7 million (Q4 2025), and $87.3 million (Q3 2025).